Paraganglioma other diagnostic studies: Difference between revisions

	Paraganglioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Paraganglioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT Scan
MRI
Echocardiography and Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Paraganglioma other diagnostic studies On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Paraganglioma other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Paraganglioma other diagnostic studies
CDC on Paraganglioma other diagnostic studies
Paraganglioma other diagnostic studies in the news
Blogs on Paraganglioma other diagnostic studies
Directions to Hospitals Treating Paraganglioma
Risk calculators and risk factors for Paraganglioma other diagnostic studies

Revision as of 16:01, 10 September 2015

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Paraganglioma}}
-{{CMG}} {{AE}} {{AAM}}
-==Overview==
-[[Immunohistochemistry]] and [[histochemistry]] are used in the diagnosis of paraganglioma.
-==Other Diagnostic Studies==
-*'''[[Immunohistochemistry]]'''
-:The chief cells are positive for [[chromogranin]], [[synaptophysin]], neuron specific enolase, [[serotonin]] and [[neurofilament]]; they are [[S-100 protein]] negative.
-*'''[[Histochemistry]]'''
-:The paraganglioma cells are argyrophilic, [[periodic acid Schiff]] negative, [[mucicarmine]] negative, and [[argentaffin]] negative.
 ==References==
 {{reflist|2}}